Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 5Unknown 4Terminated 4Recruiting 4Active not recruiting 3Not yet recruiting 2

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Triple Negative Breast Neoplasms 1Breast Neoplasms 1

Interventions

Drug Therapy 107Cisplatin 98Radiotherapy 89Carboplatin 86Bevacizumab 79Oxaliplatin 74Capecitabine 69tislelizumab 68Gemcitabine 64Cyclophosphamide 64toripalimab 62Paclitaxel 58pembrolizumab 56Specimen Handling 54sintilimab 53Surgical Procedures, Operative 52anlotinib 51Magnetic Resonance Spectroscopy 50Fluorouracil 49Immune Checkpoint Inhibitors 43Blood Specimen Collection 42130-nm albumin-bound paclitaxel 42Standard of Care 38camrelizumab 36fludarabine 35Leucovorin 34lenvatinib 33venetoclax 30Radiosurgery 30Immunotherapy 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × taxane × Clear all
NCT05843292 2023-06-06

NeoSTEP

Shanghai Jiao Tong University School of Medicine

Phase 4 Not yet recruiting
48 enrolled
Breast

Triple Negative Breast Neoplasms

NCT05172518 2021-12-29

Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast Cancer

Sun Yat-sen University

Phase 3 Not yet recruiting
512 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡